Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05556577

Weight Cycle Post Intervention

Weight Cycle Impacted by Health Lifestyle Post Pharmacotherapy Intervention

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Shanghai Zhongshan Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of this follow-up (FU) study is to examine trajectory of body weight impacted by self-reported diet patterns and physical activities in 6 months at 3 monthly intervals from treatment cessation among patients who completed a pharmacotherapy trial. In addition, patient self-reported diet patterns and physical activities at respective time points will be described.

Detailed description

This is a real-world prospective observational study with primary data collection. All participants with a background be recommended to adopt lifestyle intervention as chronic weight management in China clinical practice. This FU study will enroll patients who completed SURMOUNT-CN trials, with planed study duration of 6 months. No investigational medicine is applied in this prospective follow-up study. Patients are requested to report body weight, waist circumferences, blood pressure, diet, physical activities, and laboratory results if available, at 3 monthly intervals during the 6-month follow-up period. Patients are also asked if they receive any Anti-Obesity medication (AOM) or participate in any interventional clinical trials indicated for weight management during study period. Summary statistics will be respectively applied to examine changes from trial baseline (time at trial randomization, week 0) and study baseline (time at 52 weeks from trial randomization, week 52) to each scheduled follow-up (at week 65 and week 78) by study arms in SURMOUNT-CN trial.

Conditions

Interventions

TypeNameDescription
DRUGinvestigational medicine product (IMP)Investigational medicine product (IMP) received at SURMOUNT-CN trial
OTHERplaceboPlacebo received at SURMOUNT-CN trial

Timeline

Start date
2022-09-15
Primary completion
2023-03-15
Completion
2023-03-15
First posted
2022-09-27
Last updated
2022-11-28

Source: ClinicalTrials.gov record NCT05556577. Inclusion in this directory is not an endorsement.